Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life
- 16 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Neuroscience
- Vol. 23 (12), 1580-1588
- https://doi.org/10.1038/s41593-020-00737-w
Abstract
Amyloid-β (Aβ) deposits are a relatively late consequence of Aβ aggregation in Alzheimer‘s disease. When pathogenic Aβ seeds begin to form, propagate and spread is not known, nor are they biochemically defined. We tested various antibodies for their ability to neutralize Aβ seeds before Aβ deposition becomes detectable in Aβ precursor protein-transgenic mice. We also characterized the different antibody recognition profiles using immunoprecipitation of size-fractionated, native, mouse and human brain-derived Aβ assemblies. At least one antibody, aducanumab, after acute administration at the pre-amyloid stage, led to a significant reduction of Aβ deposition and downstream pathologies 6 months later. This demonstrates that therapeutically targetable pathogenic Aβ seeds already exist during the lag phase of protein aggregation in the brain. Thus, the preclinical phase of Alzheimer‘s disease—currently defined as Aβ deposition without clinical symptoms—may be a relatively late manifestation of a much earlier pathogenic seed formation and propagation that currently escapes detection in vivo.Keywords
This publication has 59 references indexed in Scilit:
- Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-βNature, 2012
- The Amyloid State of Proteins in Human DiseasesCell, 2012
- Transient pharmacologic lowering of Aβ production prior to deposition results in sustained reduction of amyloid plaque pathologyMolecular Neurodegeneration, 2012
- Soluble Aβ Seeds Are Potent Inducers of Cerebral β-Amyloid DepositionJournal of Neuroscience, 2011
- Peripherally Applied Aβ-Containing Inoculates Induce Cerebral β-AmyloidosisScience, 2010
- An improved method for generating consistent soluble amyloid-beta oligomer preparations for in vitro neurotoxicity studiesJournal of Neuroscience Methods, 2010
- Suppression of Amyloid Deposition Leads to Long-Term Reductions in Alzheimer's Pathologies in Tg2576 MiceJournal of Neuroscience, 2009
- Consequence of Aβ immunization on the vasculature of human Alzheimer's disease brainBrain, 2008
- Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and HostScience, 2006
- Cerebral Hemorrhage After Passive Anti-Aβ ImmunotherapyScience, 2002